Skip to main content
AREAZINENotices · US CA UK AU

MHRA26 Mar 2026

Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17

The Medicines and Healthcare products Regulatory Agency published a recall notice for Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 on 26 Mar 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.

Recall

The recall notice

Issued by
Medicines and Healthcare products Regulatory Agency
Issued
14:01, 26 Mar 2026
Alert class
Class 4 Recall
Official source
Medicines and Healthcare products Regulatory Agency: the notice at its source

The latest from the MHRAEvery warning and recall in the United Kingdom

Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.

The notice as issued

Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.

Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.

The record around this notice